CD4 and Hyperglycemia: Data depicted in figure 7B show that the cumulative incidence of hyperglycemia in RAG2 KO, RIP-HA Tg recipients of diabetogenic CD4+(Foxp3-depleted), TCR-HA+/− T-cells from untreated F1 mice was 50%, whereas in those receiving the same type of cells from squalene treated F1 mice was increased to almost 80%.